DONNA FOSTER: Open Payments
NPI 1679204044 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,433 in 164 payments from 22 companies in 2025. Trend: 2023 $654 · 2024 $1,714 · 2025 $3,433
Food & beverage: $3,348Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $757 |
| Janssen Biotech, Inc. | 16 | $629 |
| GENZYME CORPORATION | 8 | $320 |
| Madrigal Pharmaceuticals | 11 | $206 |
| Novo Nordisk Inc | 5 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $184 |
| Ardelyx, Inc. | 9 | $168 |
| Aimmune Therapeutics, Inc. | 9 | $151 |
| Ipsen Biopharmaceuticals, Inc | 5 | $110 |
| QOL Medical, LLC | 5 | $93 |
Products named: TREMFYA, DUPIXENT, RINVOQ, REZDIFFRA, Wegovy, IBSRELA, ENTYVIO, ZENPEP.
Industry payments across SC — which companies pay providers there.
